logo

BBOT

BridgeBio·NASDAQ
--
--(--)
--
--(--)
6.53 / 10
Outperform

Analyst consensus is a Strong Buy (100%) from one analyst, yet the stock fell 15.8%. Fund flow score is 7.56/10, with overall, block, small and extra‑large inflows positive, while medium and large are negative, suggesting mixed liquidity dynamics.

FundamentalSentiment(6.53)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-06
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for BBOT?
  • BBOT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.53/10 (Outperform).